Literature DB >> 5322720

Stability of beta-galactosidase messenger ribonucleic acid in Escherichia coli.

F Ben-Hamida, D Schlessinger.   

Abstract

Ben-Hamida, Fakher (Washington University School of Medicine, St. Louis, Mo.), and David Schlessinger. Stability of beta-galactosidase messenger ribonucleic acid in Escherichia coli. J. Bacteriol. 90:1611-1616. 1965.-Synthesis of beta-galactosidase stops within several minutes when preinduced, permeaseless cultures are diluted into medium containing 40 mug/ml of 5-fluorouracil (5-FU) but no inducer. However, if inducer (isopropylthiogalactoside) is left in the medium, enzyme formation in the presence of 5-FU continues for at least 11 min. Thus, inducer may increase the differential metabolic stability of the corresponding messenger ribonucleic acid (RNA; defined as the capacity to produce measurable enzyme) in inducible strains. However, such an interpretation requires that 5-FU rapidly arrest the further synthesis of messenger RNA competent to form active enzyme. C(14)-5-FU, like uracil, does appear to enter cells without measurable lag, saturating the pool of uracil nucleotides, and thereby the messenger RNA being formed, within several minutes. That 5-FU acts very quickly is also supported by the similar continuation of enzyme synthesis in the presence of inducer and antibiotics (actinomycin D and proflavine) which shut off all RNA synthesis, as well as by the response to 5-FU of enzyme synthesis in various constitutive mutants.

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5322720      PMCID: PMC315868          DOI: 10.1128/jb.90.6.1611-1616.1965

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  17 in total

1.  The amino acid pool in Escherichia coli.

Authors:  R J BRITTEN; F T McCLURE
Journal:  Bacteriol Rev       Date:  1962-09

2.  THE MOLECULAR BASIS OF HISTIDASE INDUCTION IN BACILLUS SUBTILIS.

Authors:  L H HARTWELL; B MAGASANIK
Journal:  J Mol Biol       Date:  1963-10       Impact factor: 5.469

3.  Inhibition of protein synthesis in E. coli protoplasts by actinomycin-D.

Authors:  A M HAYWOOD; R L SINSHEIMER
Journal:  J Mol Biol       Date:  1963-03       Impact factor: 5.469

4.  The synthesis and kinetic behavior of deoxyribonucleic acid-like ribonucleic acid in bacteria.

Authors:  J E MIDGLEY; B J McCARTHY
Journal:  Biochim Biophys Acta       Date:  1962-11-26

5.  Transduction by bacteriophage P-1 and the properties of the lac genetic region in E. coli and S. dysenteriae.

Authors:  N C FRANKLIN; S E LURIA
Journal:  Virology       Date:  1961-11       Impact factor: 3.616

6.  Genetic regulatory mechanisms in the synthesis of proteins.

Authors:  F JACOB; J MONOD
Journal:  J Mol Biol       Date:  1961-06       Impact factor: 5.469

7.  The initial kinetics of enzyme induction.

Authors:  A B PARDEE; L S PRESTIDGE
Journal:  Biochim Biophys Acta       Date:  1961-04-29

8.  Contributions of studies on the beta-galactosidase of Escherichia coli to our understanding of enzyme synthesis.

Authors:  M COHN
Journal:  Bacteriol Rev       Date:  1957-09

9.  Messenger RNA turnover and protein synthesis in B. subtilis inhibited by actinomycin D.

Authors:  C LEVINTHAL; A KEYNAN; A HIGA
Journal:  Proc Natl Acad Sci U S A       Date:  1962-09-15       Impact factor: 11.205

10.  Hyper-production of beta-galactosidase by Escherichia coli bacteria.

Authors:  A NOVICK; T HORIUCHI
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1961
View more
  3 in total

1.  [Definition and evaluation of the coefficient of amplification in cellular control systems].

Authors:  W A Knorre
Journal:  Biophysik       Date:  1968-08-12

2.  Protein synthesis by long-lived messenger ribonucleic acid in bacteria.

Authors:  M D Yudkin
Journal:  Biochem J       Date:  1966-08       Impact factor: 3.857

3.  Decay of normal and 5-fluorouracil-substituted messenger ribonucleic acid of alkaline phosphatase in Escherichia coli.

Authors:  E Yagil; N Silberstein
Journal:  J Bacteriol       Date:  1969-12       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.